Successful Preoperative Treatment of a Graves' Disease Patient With Agranulocytosis and Hemophagocytosis Using Double Filtration Plasmapheresis

被引:5
|
作者
Lew, Wei Han [1 ]
Chang, Chun-Jen [1 ]
Lin, Jiunn-Diann [1 ]
Cheng, Chung-Yi [2 ]
Chen, Yin-Kai [3 ]
Lee, Ting-I [1 ,4 ]
机构
[1] Taipei Med Univ, Wan Fang Hosp, Div Endocrinol & Metab, Dept Internal Med,Sect 3, Taipei, Taiwan
[2] Taipei Med Univ, Wan Fang Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan
[3] Taipei Med Univ, Wan Fang Hosp, Div Hematol & Oncol, Dept Internal Med, Taipei, Taiwan
[4] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan
关键词
Graves' disease; agranulocytosis; hemophagocytosis; plasmapheresis; DRUG-INDUCED AGRANULOCYTOSIS; HYPERTHYROIDISM;
D O I
10.1002/jca.20282
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Agranulocytosis is an uncommon but serious complication of Graves' disease under thionamide therapy. In some patients removal of circulating thyroid hormones and thyroid antibodies by plasmapheresis is an effective adjunctive therapeutic option. In perioperative settings, however, plasmapheresis may cause excess bleeding intraoperatively due to coagulation factor depletion unless fresh frozen plasma (FFP) products are used in the replacement fluid mix. Double filtration plasmapheresis (DFPP) in which only a small amount of albumin supplementation is used may be a potential alternative to conventional apheresis interventions where clotting factor depletion is problematic. We report a case of a patient with Graves' disease complicated with intravenous immunoglobulin responsive methimazole-induced agranulocytosis/hemophagocytosis who underwent successful preoperative DFPP treatment in preparation for thyriodectomy. In addition to conventional apheresis using FFP replacement, DFPP may offer an effective adjunct option in the management of hyperthyroid patients needing emergent surgical interventions. J. Clin. Apheresis 26:159-161, 2011. (C) 2011 Wiley-Liss, Inc.
引用
收藏
页码:159 / 161
页数:3
相关论文
共 50 条
  • [31] Elephantiasic Pretibial Myxedema in a Patient With Graves Disease That Resolved After 131I Treatment
    Yu, Haifang
    Jiang, Xue
    Pan, Mingzhi
    Huang, Rui
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (08) : 758 - 759
  • [32] Primary immune thrombocytopenia responding to antithyroid treatment in a patient with Graves’ disease
    Harinder Gill
    Yu-Yan Hwang
    Eric Tse
    Annals of Hematology, 2011, 90 : 223 - 224
  • [33] Remission of aplastic anemia induced by treatment for Graves disease in a pediatric patient
    Das, Prabodh Kumar
    Wherrett, Diane
    Dror, Yigal
    PEDIATRIC BLOOD & CANCER, 2007, 49 (02) : 210 - 212
  • [34] Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management
    Masiello, E.
    Veronesi, G.
    Gallo, D.
    Premoli, P.
    Bianconi, E.
    Rosetti, S.
    Cusini, C.
    Sabatino, J.
    Ippolito, S.
    Piantanida, E.
    Tanda, M. L.
    Chiovato, L.
    Wiersinga, W. M.
    Bartalena, L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2018, 41 (12): : 1425 - 1432
  • [35] Double-filtration plasmapheresis combined with immunosuppressive treatment for severe pemphigus: 10 years' experience of a single center in China
    Liu, Yan
    Zhang, Bingjie
    Ma, Jie
    Wang, Haiyun
    Fan, Xiaohong
    Zheng, Ke
    Chen, Limeng
    Li, Xuewang
    Qin, Yan
    Li, Li
    Li, Xuemei
    JOURNAL OF CLINICAL APHERESIS, 2021, 36 (01) : 20 - 27
  • [36] Antithyroid drug treatment for Graves’ disease: baseline predictive models of relapse after treatment for a patient-tailored management
    E. Masiello
    G. Veronesi
    D. Gallo
    P. Premoli
    E. Bianconi
    S. Rosetti
    C. Cusini
    J. Sabatino
    S. Ippolito
    E. Piantanida
    M. L. Tanda
    L. Chiovato
    W. M. Wiersinga
    L. Bartalena
    Journal of Endocrinological Investigation, 2018, 41 : 1425 - 1432
  • [37] Outpatient 131I Treatment for a Patient with Graves' Disease Receiving Hemodialysis
    Suzuki, Miho
    Noh, Jaeduk Yoshimura
    Sugino, Kiminori
    Ito, Koichi
    INTERNAL MEDICINE, 2016, 55 (22) : 3309 - 3313
  • [38] Can a patient-tailored treatment approach for Graves' disease reduce mortality?
    Bartalena, Luigi
    Piantanida, Eliana
    Tanda, Maria Laura
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (04) : 245 - 246
  • [39] Graves' Disease in Two Pregnancies Complicated by Fetal Goitrous Hypothyroidism: Successful In Utero Treatment with Levothyroxine
    Blidda, Sofie
    Rasmussen, Ase Krogh
    Sundberg, Karin
    Brocks, Vibeke
    Skovbo, Peter
    Feldt-Rasmussen, Ulla
    THYROID, 2011, 21 (01) : 75 - 81
  • [40] MIXED CONNECTIVE-TISSUE DISEASE - RECURRENT EPISODES OF OPTIC NEUROPATHY AND TRANSVERSE MYELOPATHY - SUCCESSFUL TREATMENT WITH PLASMAPHERESIS
    FLECHTNER, KM
    BAUM, K
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 126 (02) : 146 - 148